Specifically, this study aimed to determine whether medication used in ADHD treatment contributes to improvements in social cognitive functioning, as well as to investigate potential changes in serum oxytocin levels as a neurobiological correlate. This evidence concerns the gene OXT and attention deficit-hyperactivity disorder.